| 1 |
34952945 |
10.1038/s41379-021-01002-6 |
2022 |
Genomic landscape of Epstein-Barr virus-positive extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue. |
IRF8 |
| 2 |
35086136 |
10.1182/bloodadvances.2021004366 |
2022 |
IRF8 is a transcriptional activator of CD37 expression in diffuse large B-cell lymphoma. |
IRF8 |
| 3 |
35460405 |
10.1093/ajcp/aqac044 |
2022 |
IRF8 as a Novel Marker to Differentiate Between CD30-Positive Large Cell Lymphomas. |
IRF8 |
| 4 |
35609565 |
10.1182/bloodadvances.2022007322 |
2022 |
A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile. |
IRF8 |
| 5 |
35834399 |
10.1097/PAS.0000000000001932 |
2022 |
Pediatric-Type Indolent B-Cell Lymphomas With Overlapping Clinical, Pathologic, and Genetic Features. |
IRF8 |
| 6 |
36030374 |
10.1002/eji.202250037 |
2022 |
IRF8 regulates efficacy of therapeutic anti-CD20 monoclonal antibodies. |
IRF8 |
| 7 |
33939500 |
10.1177/10668969211013402 |
2021 |
A Pedigree Analysis and Clonal Correlations of the Coexistence of B-Cell Lymphoma and Histiocytic/Dendritic Cell Tumor. |
IRF8 |
| 8 |
34478526 |
10.1182/bloodadvances.2021005215 |
2021 |
Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype. |
IRF8 |
| 9 |
32012328 |
10.1002/hon.2718 |
2020 |
High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas. |
IRF8 |
| 10 |
32535543 |
10.1016/j.cancergen.2020.05.002 |
2020 |
Generation and characterization of the Eµ-Irf8 mouse model. |
IRF8 |
| 11 |
32546039 |
10.1080/10428194.2020.1775216 |
2020 |
TBLR1 and CREBBP as potential novel prognostic immunohistochemical biomarkers in diffuse large B-cell lymphoma. |
IRF8 |
| 12 |
33017467 |
10.1182/bloodadvances.2020002049 |
2020 |
The synergistic proapoptotic effect of PARP-1 and HDAC inhibition in cutaneous T-cell lymphoma is mediated via Blimp-1. |
IRF8 |
| 13 |
30105896 |
10.1002/jcp.27045 |
2019 |
Ameloblastin attenuates RANKL-mediated osteoclastogenesis by suppressing activation of nuclear factor of activated T-cell cytoplasmic 1 (NFATc1). |
IRF8 |
| 14 |
31000603 |
10.1073/pnas.1901258116 |
2019 |
Transcription factors IRF8 and PU.1 are required for follicular B cell development and BCL6-driven germinal center responses. |
IRF8 |
| 15 |
31024321 |
10.3389/fphar.2019.00367 |
2019 |
Inhibitory Effect of KP-A038 on Osteoclastogenesis and Inflammatory Bone Loss Is Associated With Downregulation of Blimp1. |
IRF8 |
| 16 |
31292115 |
10.1182/blood.2019001126 |
2019 |
Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma. |
IRF8 |
| 17 |
31444033 |
10.1016/j.jaut.2019.102317 |
2019 |
Genetic contributors and soluble mediators in prediction of autoimmune comorbidity. |
IRF8 |
| 18 |
29463002 |
10.3390/ijms19020601 |
2018 |
Inhibitory Effect of Purpurogallin on Osteoclast Differentiation in Vitro through the Downregulation of c-Fos and NFATc1. |
IRF8 |
| 19 |
29899297 |
10.3390/ijms19061758 |
2018 |
Molecular Mechanisms of Disease Progression in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type during Ibrutinib Therapy. |
IRF8 |
| 20 |
28533310 |
10.1182/blood-2017-03-776278 |
2017 |
Mutations of <i>MAP2K1</i> are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation. |
IRF8 |
| 21 |
28537908 |
10.18632/oncotarget.17693 |
2017 |
Increased expression of IRF8 in tumor cells inhibits the generation of Th17 cells and predicts unfavorable survival of diffuse large B cell lymphoma patients. |
IRF8 |
| 22 |
27098631 |
NA |
2016 |
Extranodal B Cell Lymphoma with Prominent Spindle Cell Features Arising in Uterus and in Maxillary Sinus: Report of Two Cases and Literature Review. |
IRF8 |
| 23 |
27338637 |
10.1038/modpathol.2016.102 |
2016 |
A study of the mutational landscape of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma. |
IRF8 |
| 24 |
26316891 |
10.7150/jca.12067 |
2015 |
Loss of IRF8 Inhibits the Growth of Diffuse Large B-cell Lymphoma. |
IRF8 |
| 25 |
23573829 |
10.3109/10428194.2013.793324 |
2014 |
IRF8 is associated with germinal center B-cell-like type of diffuse large B-cell lymphoma and exceptionally involved in translocation t(14;16)(q32.33;q24.1). |
IRF8 |
| 26 |
24435047 |
10.1182/blood-2013-05-500264 |
2014 |
Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma. |
IRF8 |
| 27 |
25265348 |
NA |
2014 |
Intrinsic defect in B-lymphoblastoid cell lines from patients with X-linked lymphoproliferative disease type 1. II. receptor-mediated Akt/PKB and ERK1/2 activation and transcription factors expression profile. |
IRF8 |
| 28 |
25331958 |
10.1074/jbc.M114.571182 |
2014 |
Interferon regulatory factor 8 (IRF8) interacts with the B cell lymphoma 6 (BCL6) corepressor BCOR. |
IRF8 |
| 29 |
23292937 |
10.1073/pnas.1205299110 |
2013 |
Genetic heterogeneity of diffuse large B-cell lymphoma. |
IRF8 |
| 30 |
23307532 |
10.1158/1055-9965.EPI-12-1217 |
2013 |
Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypes. |
IRF8 |
| 31 |
23770605 |
10.1038/ng.2652 |
2013 |
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. |
IRF8 |
| 32 |
23775715 |
10.1182/blood-2013-04-495804 |
2013 |
A capture-sequencing strategy identifies IRF8, EBF1, and APRIL as novel IGH fusion partners in B-cell lymphoma. |
IRF8 |
| 33 |
18580679 |
10.1097/PAS.0b013e318166f46a |
2008 |
Expression of the interferon regulatory factor 8/ICSBP-1 in human reactive lymphoid tissues and B-cell lymphomas: a novel germinal center marker. |
IRF8 |
| 34 |
16380510 |
10.1084/jem.20051450 |
2006 |
Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein. |
IRF8 |
| 35 |
16780917 |
10.1016/j.virol.2006.05.006 |
2006 |
The Icsbp locus is a common proviral insertion site in mature B-cell lymphomas/plasmacytomas induced by exogenous murine leukemia virus. |
IRF8 |
| 36 |
17082608 |
10.4049/jimmunol.177.10.6930 |
2006 |
Stages of germinal center transit are defined by B cell transcription factor coexpression and relative abundance. |
IRF8 |
Datasets
Models
